ASH News Daily - Saturday, December 10, 2011 - (Page B-23)

at the 2011 ASH Annual Conference to receive the Plasma Cell Neoplasms Online Chapter from the DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology 9th Edition VISIT BOOTH #1629 Image: Colored scanning electron micrograph (SEM) of a lung cancer cell. One focus: a shared commitment to improve the lives of cancer patients everywhere. Millennium: The Takeda Oncology Company is developing an extensive pipeline — among the top in oncology worldwide — with more than 17 compounds in development for a broad range of solid and hematological cancers. Our pipeline — rich in novel compounds — includes multiple candidates that target seven disease pathways: protein homeostasis, anti-angiogenesis, growth-signaling inhibition, cell-cycle inhibition, apoptosis, immunomodulators and hormone regulation. To make a dramatic impact on cancer therapeutics, we are dedicated to a strong partnership with the oncology community. Stop by the Millennium booth to learn more about our commitment and take part in our 1000 Cranes of Hope Initiative. WHAT IS YOUR WISH? Visit the 1000 Cranes of Hope exhibit to help in the advancement of research and patient support. As each person’s wishes and dreams join ours, Millennium will provide a charitable grant to the ASH Clinical/Translational Scholar Awards in support of quality research that will have an impact on current and future patients. JOIN US AT BOOTH #1629 TO ENJOY CHURROS, MEXICAN HOT CHOCOLATE, WATER, AND COFFEE DURING EXHIBIT HOURS. To learn more, visit us at millennium.com. ©2011 Millennium Pharmaceuticals, Inc. All rights reserved. ASH Daily_10x14.indd 1 9/29/11 11:01 AM

Table of Contents for the Digital Edition of ASH News Daily - Saturday, December 10, 2011

ASH News Daily - Saturday, December 10, 2011

https://www.nxtbookmedia.com